As depicted in Figures 3A, C, D, in contrast to the control group, a remarkable augmentation in the quantity of tumor-infiltrating cytotoxic T cells (CD3+/CD8+) has been observed in both LS and MS groups. The gene discussed is CD8A; the disease is neoplasm.